Skip to content

Thursday, May 14, 2026

Latest:

Big hair, sun don’t care!
A body’s response that protects from atherosclerosis
A non-invasive treatment gives a steady outlook
Summer skin care – what you need to know
A safe house for tumors: method reveals cellular makeup of tissues that favor metastatic cancer growth

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

brittle bone disease

Targeting TGF-β for treatment of osteogenesis imperfecta

March 22, 2022 brittle bone disease, fresolimumab, osteogenesis imperfecta, Research, TGF-β, treatment

A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.

andersson-dyke-featured-photo

Young author raises brittle bone disease awareness, receives prestigious award

August 8, 2016 Affiliates, Allison Mickey, Andersson Dyke, Awards and Honors, brittle bone disease, Dr. Brendan Lee, Genetics, molecular and human genetics, osteogenesis imperfecta, Osteogenesis Imperfecta Foundation, pediatrics, Texas Children's Hospital

When she was nine years old, Andersson Dyke, a cat lover, began imagining an idea for a story; the journey of an abandoned lion cub

From the Labs: Image of the Month

From the Labs: Breast cancer cell clusters

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951